Intratumoral CCR8+ Tregs exhibit enhanced immunosuppressive activity compared to peripheral Tregs, making CCR8 an attractive target for selectively depleting tumor-infiltrating Tregs while preserving systemic immune homeostasis [146]. This evidence concerns the gene CCR8 and neoplasm.